Series A Therapeutics Companies

Antag Therapeutics provides therapeutic peptides for the treatment of dietary-related metabolic diseases.

PreComb develops technologies to optimally adapt the therapies to each patient for difficult-to-treat cancers.

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies.

Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.

TES Pharma is a research-based biopharmaceutical company.

Greenlight Health is a digital health platform that helps researchers and clinicians create validated real-world programs.

Ambros Therapeutics is a clinical-stage biotechnology company.

Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen.

Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs.

Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

ProLynx is a biotechnology company that develops proprietary drug-delivery technologies to extend the half-life of therapeutic molecules.

Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.

Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.

Topography Health encourages physicians in private practice to participate in clinical trials in order to advance medical research.

MYNDUP is a workplace mental health and wellbeing platform.

IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis.

Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS).

Multus is a global leader in cell culture media design for cell-based biomanufacturing, combining AI, robotic automation, and cell biology.

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

OYE Therapeutics is a clinical-stage pharmaceutical development company that develops anesthesia drugs.